Search
OptimizeRx Corp
OPRXAdd to Watchlist
7.720USD
+0.120+1.58%
Market hours 09/24, 14:49（ET）
144.90MMarket Cap
20.91P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.58%
5 Days
+2.52%
1 Month
+0.13%
6 Months
+20.06%
Year to Date
-37.03%
1 Year
-59.50%
Key Figures
7.510Open
7.830High
9.57KVolume
20.91P/E TTM
6.75P/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
7.600Prev. Close
7.350Low
72.09KTurnover
LossP/E Static
1.10P/B
0.00%Div Yield TTM
4.08%ROA
22.25052wk High
0.07Volume Ratio
-20.11MNet Profit
18.77MShares
0.3693EPS TTM
1.14Beta
5.56%ROE
4.54052wk Low
6.32%Amplitude
71.32%Gross Margin
144.90MMarket Cap
7.82Reward/Risk
4.55%Risk Rate
OptimizeRx Corp's Score
0.16vs previous score
Forecast8.67
Financial Health6.89
Technical4.07
Valuation Dimensions6.89
Institutional Confidence7.00
Risk Assessment3.58
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
OptimizeRx Corp Technical Analysis
Technical Indicators
Neutral
Summary
Buy
Moving Average
Strong buy
OptimizeRx Corp Latest Earnings Call Transcripts
OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30%
OptimizeRx Q2 2026 revenue fell 30% to $20.5 million, while management reaffirmed its $95 million-$100 million full-year revenue guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.04/0.12
Revenue / Forecast
20.50M/20.20M
OptimizeRx Corp Profile
SectorSoftware & IT Services
Ticker SymbolOPRX
Number of employees106
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Whetstone Capital Advisors, LLC | 8.04% |
| Weintraub (Michael) | 7.38% |
| BlackRock Institutional Trust Company, N.A. | 5.76% |
| Royce Investment Partners | 4.73% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 35.58% |
| Investment Advisor/Hedge Fund | 22.54% |
| Individual Investor | 12.68% |
| Hedge Fund | 11.85% |
Related Instruments
+1.13%
+0.82%
-0.60%
+4.59%
+1.47%
+0.72%
+0.28%
-3.22%
-0.06%
+0.64%
+0.45%
+0.20%
-0.72%
-2.27%
+1.06%
+1.55%
-1.53%
-0.19%
+1.07%
+3.22%Popular Instruments
51338.400
-151.600 (-0.29%)
30459.000
-18.900 (-0.06%)
7705.500
-1.500 (-0.02%)
14264.000
-158.000 (-1.10%)
65785.000
-344.000 (-0.52%)
6304.200
+14.200 (+0.23%)
94.843
+2.353 (+2.54%)
337.730
+0.710 (+0.21%)
223.875
-1.635 (-0.72%)
4270.060
-16.180 (-0.38%)
FAQs
What is the current price of OptimizeRx Corp (OPRX)?
The current price of OptimizeRx Corp (OPRX) is 7.60.
What is the symbol of OptimizeRx Corp?
The ticker symbol of OptimizeRx Corp is OPRX.
What is the 52-week high of OptimizeRx Corp?
The 52-week high of OptimizeRx Corp is 22.25.
What is the 52-week low of OptimizeRx Corp?
The 52-week low of OptimizeRx Corp is 4.54.
What is the market capitalization of OptimizeRx Corp?
The market capitalization of OptimizeRx Corp is 142.65M.
Is OptimizeRx Corp (OPRX) currently rated as Buy, Hold, or Sell?
According to analysts, OptimizeRx Corp (OPRX) has an overall rating of Buy, with a price target of 12.40.
What is the Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX)?
The Earnings Per Share (EPS TTM) of OptimizeRx Corp (OPRX) is 0.37.